Results 111 to 120 of about 490,601 (215)

Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients

open access: yes
International audienceSelected diffuse malignant peritoneal mesothelioma (DMPM) patients may be radically treated with complete cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Goéré, Diane   +104 more
core   +1 more source

The impact of surgical staging in patients with colorectal peritoneal metastases scheduled for CRS-HIPEC

open access: yesPleura and Peritoneum
Surgical staging procedures are used to select patients with peritoneal metastases for surgery. We aimed to evaluate the impact of surgical staging procedures and the risk of abdominal wall recurrences in patients with peritoneal metastases scheduled for
Ghanipour Lana   +3 more
doaj   +1 more source

Thromboelastogram changes are associated with postoperative complications after cytoreductive surgery

open access: yesPleura and Peritoneum
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is used to treat peritoneal surface malignancies. However, surgical morbidity is high, and prediction of severe postoperative complications (SPC) is limited.
Goder Noam   +8 more
doaj   +1 more source

Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy

open access: yesCancer Management and Research, 2012
Daniel L Chan, David L Morris, Archana Rao, Terence C ChuaHepatobiliary and Surgical Oncology Unit, UNSW Department of Surgery, and the St George Clinical School, University of New South Wales, St George Hospital, Kogarah, NSW, AustraliaPurpose: To ...
Chua TC, Rao A, Morris DL, Chan DL
doaj  

Intraperitoneal Chemotherapy Strategies in Pancreatic Ductal Adenocarcinoma: A Systematic Review of Hyperthermic Intraperitoneal Chemotherapy, Normothermic Intraperitoneal Chemotherapy, and Pressurized Intraperitoneal Aerosol Chemotherapy

open access: yes
Background: Peritoneal metastasis represents an aggressive disease pattern in pancreatic ductal adenocarcinoma (PDAC), traditionally associated with poor survival and limited therapeutic options.
Hani M. Babiker   +17 more
core   +1 more source

Textbook oncologic outcomes after cytoreductive surgery and HIPEC for colorectal peritoneal metastases: a single-centre cohort analysis

open access: yesPleura and Peritoneum
Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is an established treatment for selected patients with colorectal peritoneal metastases (CPM).
Brindl Niall   +6 more
doaj   +1 more source

Conversion Therapy for Gastric Cancer with Peritoneal Metastasis

open access: yesSiriraj Medical Journal
Peritoneal metastasis in gastric cancer has a poor prognosis and is increasing in prevalence. Neoadjuvant chemotherapy is used for advanced tumors; however, surgery is generally not considered for metastatic and unresectable diseases.
Thita Intralawan   +9 more
doaj  

Home - About - Disclaimer - Privacy